Thomas G. Townes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thomas G. Townes has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Amit Moran
Department of Head and Neck Surgery University of Texas MD Anderson Cancer Center Houston Texas USA
1 shared publicationAnastasios Maniakas
Department of Head and Neck Surgery University of Texas MD Anderson Cancer Center Houston Texas USA
1 shared publicationAndrew G. Sikora
Department of Head and Neck Surgery University of Texas MD Anderson Cancer Center Houston Texas USA
1 shared publicationAnna Lee
Department of Radiation Oncology University of Texas MD Anderson Cancer Center Houston Texas USA
1 shared publicationCarol M. Lewis
Department of Head and Neck Surgery University of Texas MD Anderson Cancer Center Houston Texas USA
1 shared publication- Edward I. Chang
From the Department of Plastic Surgery, University of Texas MD Anderson Cancer Center
1 shared publication
Latest Publications
- 30 April 2026
- Published by Wiley in Otolaryngology–Head and Neck Surgery
A Standardized Algorithm's Impact on Primary Detection in Head and Neck Carcinoma of Unknown Primary
Objective(s): National guidelines for HPV‐associated head and neck squamous cell carcinoma of unknown primary (HNSCCUP) were adapted into a standardized institutional diagnostic algorithm. This study evaluated the impact of algorithm implementation on primary site detection, treatment selection, and oncologic outcomes. Study Design: Retrospective implementation study. Setting: Single tertiary‐care cancer center. Methods: We reviewed patients with clinically occult, PET/CT nonlocalizing HPV‐associated HNSCCUP treated before (2014‐2021) and after (2022‐2023) implementation of the algorithm. Results: Among 139 patients, those treated after algorithm implementation (n = 33) were more likely to undergo robotic ipsilateral lingual ± palatine tonsillectomy rather than bilateral palatine tonsillectomy, resulting in higher mucosal detection rates (88% vs 59%, P = .003). Postimplementation patients were more likely to receive primary surgical rather than nonsurgical treatment (54% vs 20%, P < .001) and unilateral radiotherapy without elective contralateral nodal irradiation (78% vs 43.5%, P = .002). Algorithm implementation was associated with a fourfold increase in the odds of primary site detection (OR 4.1, 95% CI 1.3‐13.0, P = .018); however, detection rates also increased in HNSCCUPs not managed with robotic surgery, from 57% to 87% ( P = .04). After implementation, 21.2% of patients received surgery alone compared with 5.7% prior, while postoperative chemoradiation was used in 9.1% versus 3.8%, respectively. No locoregional failures have occurred since implementation. Conclusion: Implementation of a standardized diagnostic algorithm for HPV‐associated HNSCCUP significantly improved primary site detection and altered treatment without compromising disease control. Improvements in detection were not fully explained by the use of robotic surgery. Potential functional benefits warrant further study. Level of Evidence: 4.
- 30 April 2026
- Published by Wiley in Otolaryngology–Head and Neck Surgery
A Standardized Algorithm's Impact on Primary Detection in Head and Neck Carcinoma of Unknown Primary
Objective(s): National guidelines for HPV‐associated head and neck squamous cell carcinoma of unknown primary (HNSCCUP) were adapted into a standardized institutional diagnostic algorithm. This study evaluated the impact of algorithm implementation on primary site detection, treatment selection, and oncologic outcomes. Study Design: Retrospective implementation study. Setting: Single tertiary‐care cancer center. Methods: We reviewed patients with clinically occult, PET/CT nonlocalizing HPV‐associated HNSCCUP treated before (2014‐2021) and after (2022‐2023) implementation of the algorithm. Results: Among 139 patients, those treated after algorithm implementation (n = 33) were more likely to undergo robotic ipsilateral lingual ± palatine tonsillectomy rather than bilateral palatine tonsillectomy, resulting in higher mucosal detection rates (88% vs 59%, P = .003). Postimplementation patients were more likely to receive primary surgical rather than nonsurgical treatment (54% vs 20%, P < .001) and unilateral radiotherapy without elective contralateral nodal irradiation (78% vs 43.5%, P = .002). Algorithm implementation was associated with a fourfold increase in the odds of primary site detection (OR 4.1, 95% CI 1.3‐13.0, P = .018); however, detection rates also increased in HNSCCUPs not managed with robotic surgery, from 57% to 87% ( P = .04). After implementation, 21.2% of patients received surgery alone compared with 5.7% prior, while postoperative chemoradiation was used in 9.1% versus 3.8%, respectively. No locoregional failures have occurred since implementation. Conclusion: Implementation of a standardized diagnostic algorithm for HPV‐associated HNSCCUP significantly improved primary site detection and altered treatment without compromising disease control. Improvements in detection were not fully explained by the use of robotic surgery. Potential functional benefits warrant further study. Level of Evidence: 4.
- 17 November 2025
- Published by Wiley in Head & Neck
- Vol. 48 (4) , 967-974
Microvascular Free Tissue Transfer for Reconstruction of Anterior Skull Base Defects
Background: We present our experience with free flap reconstruction of the anterior skull base (SB), focusing on complex composite defects in patients undergoing multimodality therapy for SB tumors. Methods: Outcomes of patients undergoing anterior SB free flap reconstruction were retrospectively analyzed. Results: Sixty‐three free flap reconstructions of the anterior SB were performed. Open maxillectomy (56%) and craniofacial resection (46%) were the most common ablative approaches. The anterolateral thigh (ALT) flap was the most common reconstructive method (84%), including chimeric ALT flaps used in 70% of the patients to reconstruct defects that encompassed more than one subsite. Twenty‐one (33%) patients experienced a complication within 30 days after reconstruction. There were no cases of surgical mortality. Conclusions: Microvascular free tissue transfer is an effective reconstructive option for the anterior SB. Chimeric free flaps are often best suited for the reconstruction of the anterior SB due to the flexibility of inset, allowing adjacent areas to be reconstructed without adding undesirable bulk.
- 17 November 2025
- Published by Wiley in Head & Neck
- Vol. 48 (4) , 967-974
Microvascular Free Tissue Transfer for Reconstruction of Anterior Skull Base Defects
Background: We present our experience with free flap reconstruction of the anterior skull base (SB), focusing on complex composite defects in patients undergoing multimodality therapy for SB tumors. Methods: Outcomes of patients undergoing anterior SB free flap reconstruction were retrospectively analyzed. Results: Sixty‐three free flap reconstructions of the anterior SB were performed. Open maxillectomy (56%) and craniofacial resection (46%) were the most common ablative approaches. The anterolateral thigh (ALT) flap was the most common reconstructive method (84%), including chimeric ALT flaps used in 70% of the patients to reconstruct defects that encompassed more than one subsite. Twenty‐one (33%) patients experienced a complication within 30 days after reconstruction. There were no cases of surgical mortality. Conclusions: Microvascular free tissue transfer is an effective reconstructive option for the anterior SB. Chimeric free flaps are often best suited for the reconstruction of the anterior SB due to the flexibility of inset, allowing adjacent areas to be reconstructed without adding undesirable bulk.